Viewing Study NCT06115135

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:09 PM
Ignite Modification Date: 2025-12-27 @ 1:13 PM
Study NCT ID: NCT06115135
Status: RECRUITING
Last Update Posted: 2025-01-16
First Post: 2023-08-11
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of Venetoclax in Combination With Isatuximab and Dexamethasone for Relapsed/Refractory Multiple Myeloma
Sponsor: Oncotherapeutics
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma in Relapse View
None Multiple Myeloma, Refractory View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Multiple Myeloma View
None MM View
None RRMM View
None Relapsed/Refractory Multiple Myeloma View